Cytokines Affecting Megakaryocytopoiesis in Rheumatoid Arthritis with Thrombocytosis

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 1996 Jan 1

PMID 8783415

Citations 6

Authors

I Ertenli

I C Haznedaroglu

S Kiraz

I Celik

M Calguneri

S Kirazhi

Affiliations

Soon will be listed here.

Abstract

Particular interleukins, namely interleukin (IL)-6, IL-4 and IL-1, with pro-inflammatory mediator activities have also been shown to be involved in the regulation of megakaryocytopoiesis. As rheumatoid arthritis (RA) is not uncommonly associated with reactive thrombocytosis, we investigated serum IL-1 alpha, IL-1 beta, IL-4 and IL-6 concentrations in RA patients with marked thrombocytosis, and compared them to the levels in RA patients with normal platelet counts and healthy volunteers. IL-1 beta. IL-4 and IL-6 concentrations were found to be correlated with the disease activity in both groups of RA patients, with higher serum levels of each cytokine in the thrombocythaemic group. Significant positive correlations of IL-1 beta and IL-4 with the platelet counts were documented only in patients with thrombocytosis. According to our results. IL-6 and IL-1 beta were found to be good indicators of disease activity in RA, while IL-1 beta and IL-4 seemed to be related more with the process of reactive thrombocytosis secondary to rheumatoid inflammation.

Citing Articles

Accelerated Spatial Fibrin Growth and Impaired Contraction of Blood Clots in Patients with Rheumatoid Arthritis.

Peshkova A, Evdokimova T, Sibgatullin T, Ataullakhanov F, Litvinov R, Weisel J Int J Mol Sci. 2020; 21(24).

PMID: 33322373 PMC: 7764115. DOI: 10.3390/ijms21249434.

A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis.

Talukdar M, Barui G, Adhikari A, Karmakar R, Ghosh U, Das T J Clin Diagn Res. 2017; 11(1):EC01-EC04.

PMID: 28273969 PMC: 5324414. DOI: 10.7860/JCDR/2017/23524.9130.

Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity.

Tasoglu O, Sahin A, Karatas G, Koyuncu E, Tasoglu I, Tecimel O Medicine (Baltimore). 2017; 96(6):e6073.

PMID: 28178164 PMC: 5313021. DOI: 10.1097/MD.0000000000006073.

Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis.

Hodkinson B, Musenge E, Ally M, Meyer P, Anderson R, Tikly M Clin Rheumatol. 2011; 31(4):613-9.

PMID: 22134750 DOI: 10.1007/s10067-011-1900-5.

Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature.

Davidovici B, Sullivan-Whalen M, Gilleaudeau P, Krueger J BMC Dermatol. 2010; 10:2.

PMID: 20356400 PMC: 2860341. DOI: 10.1186/1471-5945-10-2.

References

Luqmani R, Sheeran T, Robinson M, Richardson K, Winkles J, Emery P . Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol. 1994; 12(5):503-8. View

Madhok R, Crilly A, Watson J, Capell H . Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1993; 52(3):232-4. PMC: 1005024. DOI: 10.1136/ard.52.3.232. View

Miossec P, Naviliat M, Dupuy dAngeac A, Sany J, Banchereau J . Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis Rheum. 1990; 33(8):1180-7. DOI: 10.1002/art.1780330819. View

Arend W, Dayer J . Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990; 33(3):305-15. DOI: 10.1002/art.1780330302. View

Suzuki H, Sugiyama E, Tunru I, Yamashita N, Matsuno H, Hamazaki T . Suppressive effect of interleukin-4 (IL-4) on IL-6 production by adherent rheumatoid synovial cells. Clin Immunol Immunopathol. 1993; 66(1):67-72. DOI: 10.1006/clin.1993.1009. View

Fontana A, Hengartner H, Weber E, Fehr K, Grob P, Cohen G . Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int. 1982; 2(2):49-53. DOI: 10.1007/BF00541245. View

Hollen C, Henthorn J, Koziol J, BURSTEIN S . Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br J Haematol. 1991; 79(2):286-90. DOI: 10.1111/j.1365-2141.1991.tb04534.x. View

Gewirtz A . Megakaryocytopoiesis: the state of the art. Thromb Haemost. 1995; 74(1):204-9. View

Vellenga E, Dokter W, Halie R . Interleukin-4 and its receptor; modulating effects on immature and mature hematopoietic cells. Leukemia. 1993; 7(8):1131-41. View

10.

Mizel S . The interleukins. FASEB J. 1989; 3(12):2379-88. DOI: 10.1096/fasebj.3.12.2676681. View

11.

Dan K, Gomi S, Inokuchi K, Ogata K, Yamada T, Ohki I . Effects of interleukin-1 and tumor necrosis factor on megakaryocytopoiesis: mechanism of reactive thrombocytosis. Acta Haematol. 1995; 93(2-4):67-72. DOI: 10.1159/000204114. View

12.

Crilly A, Madhok R . Relationship between interleukin-6 levels and platelet counts in systemic juvenile rheumatoid arthritis: comment on the article by De Benedetti et al. Arthritis Rheum. 1992; 35(7):840. DOI: 10.1002/art.1780350723. View

13.

Davis M, Dawes P . A disease activity index: its use in clinical trials and disease assessment in patients with rheumatoid arthritis. Semin Arthritis Rheum. 1993; 23(2 Suppl 1):50-6. DOI: 10.1016/s0049-0172(10)80007-1. View

14.

De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio G, Martini A . Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum. 1991; 34(9):1158-63. DOI: 10.1002/art.1780340912. View

15.

Sonoda Y, Kuzuyama Y, Tanaka S, Yokota S, Maekawa T, Clark S . Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood. 1993; 81(3):624-30. View

16.

Rennick D, Jackson J, Yang G, Wideman J, Lee F, Hudak S . Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. Blood. 1989; 73(7):1828-35. View

17.

Sakito S, Ueki Y, Eguchi K, Kawabe Y, Nagataki S . Serum cytokines in patients with rheumatoid arthritis. Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells. Rheumatol Int. 1995; 15(1):31-7. DOI: 10.1007/BF00286766. View

18.

Smeland E, Blomhoff H, Funderud S, Shalaby M, Espevik T . Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes. J Exp Med. 1989; 170(4):1463-8. PMC: 2189485. DOI: 10.1084/jem.170.4.1463. View

19.

Firestein G . Cytokine networks in rheumatoid arthritis: implications for therapy. Agents Actions Suppl. 1995; 47:37-51. DOI: 10.1007/978-3-0348-7343-7_3. View

20.

Peschel C, Paul W, OHara J, Green I . Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells. Blood. 1987; 70(1):254-63. View